A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes-Reference-Cited by-同舟云学术

A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes

Published:2022-11-24 Issue:3 Volume:12 Page:2875-2884
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Makhnoon Sukh¹^ORCID,Levin Brooke²,Ensinger Megan³,Mattie Kristin²,Volk Robert J.⁴^ORCID,Zhao Zhongming⁵,Mendoza Tito⁶^ORCID,Shete Sanjay⁷^ORCID,Samiian Laila⁸,Grana Generosa²,Grainger Andrew³,Arun Banu⁹,Shirts Brian H.¹⁰,Peterson Susan K.¹

Affiliation:

1. Department of Behavioral Science UT MD Anderson Cancer Center Houston Texas USA

2. William G. Rohrer Cancer Genetics Program, Division of Hematology and Medical Oncology MD Anderson Cancer Center at Cooper University Health Care Camden New Jersey USA

3. OhioHealth Cancer Genetics Program Columbus Ohio USA

4. Department of Health Services Research UT MD Anderson Cancer Center Houston Texas USA

5. Center for Precision Health, School of Biomedical Informatics The University of Texas Health Science Center at Houston Houston Texas USA

6. Department of Symptoms research UT MD Anderson Cancer Center Houston Texas USA

7. Division of Cancer Prevention and Population Sciences UT MD Anderson Cancer Center Houston Texas USA

8. Baptist MD Anderson Jacksonville Florida USA

9. Clinical Cancer Genetics UT MD Anderson Cancer Center Houston Texas USA

10. University of Washington Seattle WA USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5202

Reference23 articles.

1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

2. Variant Interpretation: Functional Assays to the Rescue

3. Multicenter prospective cohort study of the diagnostic yield and patient experience of multiplex gene panel testing for hereditary cancer risk;K. A. Idos GE;JCO Precis Oncol,2019

4. Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories

5. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk-reducing surgeries for breast cancer in Brazilian patients undergoing multigene germline panel: impact of results on decision making;Breast Cancer Research and Treatment;2024-09-10

2. Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis;Journal of Personalized Medicine;2024-08-15

3. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-07-20

4. Disparate Rates of Germline Variants in Cancer Predisposition Genes in African American/Black Compared With Non-Hispanic White Individuals Between 2015 and 2022;JCO Precision Oncology;2024-07

5. What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open‐ended survey responses;Cancer;2024-06-06